Cargando…
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
Migraine is a highly prevalent, severe, and disabling neurological condition with a significant unmet need for effective acute therapies. Patients (~50%) are dissatisfied with their currently available therapies. Calcitonin gene-related peptide (CGRP) has emerged as a key neuropeptide involved in th...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935646/ https://www.ncbi.nlm.nih.gov/pubmed/29556965 http://dx.doi.org/10.1007/s13311-018-0617-4 |